Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia-Reference-Cited by-同舟云学术

Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia

Published:2014-12 Issue:1 Volume:11 Page:
ISSN:1742-2094
Container-title:Journal of Neuroinflammation
language:en
Short-container-title:J Neuroinflammation

Author:

Clausen Bettina Hjelm,Degn Matilda,Martin Nellie Anne,Couch Yvonne,Karimi Leena,Ormhøj Maria,Mortensen Maria-Louise Bergholdt,Gredal Hanne Birgit,Gardiner Chris,Sargent Ian IL,Szymkowski David E,Petit Géraldine H,Deierborg Tomas,Finsen Bente,Anthony Daniel Clive,Lambertsen Kate Lykke

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology,Immunology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1186/s12974-014-0203-6.pdf

Reference45 articles.

1. Lambertsen KL, Biber K, Finsen B: Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab. 2012, 32: 1677-1698. 10.1038/jcbfm.2012.88.

2. Alexopoulou L, Kranidioti K, Xanthoulea S, Denis M, Kotanidou A, Douni E, Blackshear PJ, Kontoyiannis DL, Kollias G: Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity. Eur J Immunol. 2006, 36: 2768-2780. 10.1002/eji.200635921.

3. Brambilla R, Ashbaugh JJ, Magliozzi R, Dellarole A, Karmally S, Szymkowski DE, Bethea JR: Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain. 2011, 134: 2736-2754. 10.1093/brain/awr199.

4. Ruuls SR, Hoek RM, Ngo VN, McNeil T, Lucian LA, Janatpour MJ, Korner H, Scheerens H, Hessel EM, Cyster JG, McEvoy LM, Sedgwick JD: Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity. 2001, 15: 533-543. 10.1016/S1074-7613(01)00215-1.

5. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R: Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006, 367: 29-35. 10.1016/S0140-6736(05)67763-X.

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of cytokines in neuroinflammation-mediated stroke;Cytokine & Growth Factor Reviews;2024-08

2. Blood-based protein biomarkers during the acute ischemic stroke treatment window: a systematic review;Frontiers in Neurology;2024-07-18

3. Mechanisms of inflammation after ischemic stroke in brain-peripheral crosstalk;Frontiers in Molecular Neuroscience;2024-06-12

4. Molecular Pathogenesis of Ischemic and Hemorrhagic Strokes: Background and Therapeutic Approaches;International Journal of Molecular Sciences;2024-06-07

5. Systemic treatment with a selective TNFR2 agonist alters the central and peripheral immune responses and transiently improves functional outcome after experimental ischemic stroke;Journal of Neuroimmunology;2023-12